The Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs)
Forecasted
The Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) supports early-career scientists testing innovative imaging and therapy ideas to build preliminary evidence for further research.
Browse similar grants
Funder: Education and Research Foundation for Nuclear Medicine and Molecular Imaging
Due Dates (Anticipated): August 2027 (Application deadline)
Funding Amounts: $100,000 total over two years
Summary: Supports early-career scientists developing preliminary evidence for innovative nuclear medicine and molecular imaging research in neuroendocrine tumors.
Key Information: Applicants must be no more than five years post-training and must not have been PI of a peer-reviewed grant exceeding $100,000 in a single calendar year.
Description
The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF), with sponsorship from the Neuroendocrine Tumor Research Foundation (NETRF), supports early-career basic and clinical scientists pursuing novel research in neuroendocrine tumors (NETs). The grant helps investigators develop preliminary evidence and test the feasibility of innovative ideas, building a foundation for further funding from foundations, corporations, or government agencies.
Preference is given to translational in vivo studies involving radionuclide imaging or therapy for NETs. The program seeks original, innovative, non-incremental work that advances molecular imaging and rests on sound scientific reasoning and methodology. It forms part of ERF’s broader grants, awards, and scholarship program supporting SNMMI’s commitment to developing the next generation of researchers and advancing molecular imaging and therapy.
